<SEC-DOCUMENT>0001213900-26-095093-index.html : 20260828
<SEC-HEADER>0001213900-26-095093.hdr.sgml : 20260828
<ACCEPTANCE-DATETIME>20260828163138
ACCESSION NUMBER: 0001213900-26-095093
CONFORMED SUBMISSION TYPE: 8-K
PUBLIC DOCUMENT COUNT: 12
CONFORMED PERIOD OF REPORT: 20260825
ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION: Financial Statements and Exhibits
FILED AS OF DATE: 20260828
DATE AS OF CHANGE: 20260828

FILER:

 COMPANY DATA: 
 COMPANY CONFORMED NAME: Vyome Holdings, Inc
 CENTRAL INDEX KEY: 0001427570
 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
 ORGANIZATION NAME: 03 Life Sciences
 EIN: 000000000
 STATE OF INCORPORATION: DE
 FISCAL YEAR END: 1231

 FILING VALUES:
 FORM TYPE: 8-K
 SEC ACT: 1934 Act
 SEC FILE NUMBER: 001-37897
 FILM NUMBER: 261340814

 BUSINESS ADDRESS: 
 STREET 1: 1001 CALLE AMANECER
 CITY: SAN CLEMENTE
 STATE: CA
 ZIP: 92673
 BUSINESS PHONE: 949-429-6680

 MAIL ADDRESS: 
 STREET 1: 1001 CALLE AMANECER
 CITY: SAN CLEMENTE
 STATE: CA
 ZIP: 92673

 FORMER COMPANY: 
 FORMER CONFORMED NAME: ReShape Lifesciences Inc.
 DATE OF NAME CHANGE: 20210621

 FORMER COMPANY: 
 FORMER CONFORMED NAME: OBALON THERAPEUTICS INC
 DATE OF NAME CHANGE: 20080220
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ea0303860-8k_vyome.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>
Document 1 - file: ea0303860-8k_vyome.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ea030386001ex10-1.htm
<DESCRIPTION>CONSULTING AGREEMENT, DATED AUGUST 27, 2026, BY AND AMONG VYOME HOLDINGS, INC., CLEARBRIDGECFO, LLC, AND JERRY LEONARD
<TEXT>
Document 2 - file: ea030386001ex10-1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>hind-20260825.xsd
<DESCRIPTION>XBRL SCHEMA FILE
<TEXT>
Document 3 - file: hind-20260825.xsd

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>hind-20260825_lab.xml
<DESCRIPTION>XBRL LABEL FILE
<TEXT>
Document 4 - file: hind-20260825_lab.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>hind-20260825_pre.xml
<DESCRIPTION>XBRL PRESENTATION FILE
<TEXT>
Document 5 - file: hind-20260825_pre.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 7 - file: R1.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 8 - file: report.css

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 9 - file: Show.js

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 11 - file: FilingSummary.html

Document 11 - RAW XML: FilingSummary.xml

</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>13
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 13 - file: MetaLinks.json

</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>14
<FILENAME>0001213900-26-095093-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 14 - file: 0001213900-26-095093-xbrl.zip

</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>ea0303860-8k_vyome_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
Document 15 - file: ea0303860-8k_vyome_htm.html

Document 15 - RAW XML: ea0303860-8k_vyome_htm.xml

</DOCUMENT>
</SEC-DOCUMENT>